Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells

Blood

Volumn 119, Issue 13, 2012, Pages

  Bortoluzzi, Stefania ^a   Bisognin, Andrea ^a   Biasiolo, Marta ^a   Guglielmelli, Paola ^b   Biamonte, Flavia ^b   Norfo, Ruggiero ^c   Manfredini, Rossella ^c   Vannucchi, Alessandro M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; MICRORNA; MICRORNA OFFSET RNA; RNA; RUXOLITINIB; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CELL STRAIN; CELL STRAIN SET2; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SEQUENCE; SEQUENCE ANALYSIS;

EID: 84859294576     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-368001     Document Type: Article

References (35)

1. Vannucchi AM, Guglielmelli P, Tefferi A. Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin. 2009; 59(3):171-191.
2. Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007;7(9):673-683. (Pubitemid 47327415)
3. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia. 2010;24(6):1128-1138.
4. Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA. New mutations and pathogenesis of myeloproliferative neoplasms. Blood. 2011; 118(7):1723-1735.
5. Li J, Kent DG, Chen E, Green AR. Mouse models of myeloproliferative neoplasms: JAK of all grades. Dis Model Mech. 2011;4(3):311-317.
6. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005; 434(7037):1144-1148. (Pubitemid 40663494)
7. Vannucchi AM, Guglielmelli P, Rambaldi A, Bogani C, Barbui T. Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives. J Cell Mol Med. 2009;13:1437-1450.
8. Tefferi A, Abdel-Wahab O, Cervantes F, et al. Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: proceedings from the 5th International Post-ASH Symposium. Blood Cancer J. 2011;1:e7.
9. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol. 2007;35(11):1657-1667. (Pubitemid 47633777)
10. Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica. 2008;93(7):1009-1016. (Pubitemid 351957018)
11. Guglielmelli P, Tozzi L, Pancrazzi A, et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol. 2007;35(11):1708-1718.
12. Lionetti M, Biasiolo M, Agnelli L, et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood. 2009;114(25):e20-e26.
13. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9(10): 775-789.
14. Guglielmelli P, Tozzi L, Bogani C, et al. Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera. Blood. 2011;117(25):6923-6927.
15. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228-234.
16. Burroughs AM, Ando Y, de Hoon ML, et al. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol. 2011;8(1):158-177.
17. Ro S, Park C, Jin J, Sanders KM, Yan W. A PCR-based method for detection and quantification of small RNAs. Biochem Biophys Res Commun. 2006;351(3):756-763. (Pubitemid 44708874)
18. Kuchenbauer F, Mah SM, Heuser M, et al. Comprehensive analysis of mammalian miRNA*species and their role in myeloid cells. Blood. 2011; 118(12):3350-3358.
19. Biasiolo M, Sales G, Lionetti M, et al. Impact of host genes and strand selection on miRNA and miRNA*expression. PLoS One. 2011;6(8): e23854.
20. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011; 39(suppl 1):D152-D157.
21. Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116(23): e118-e127.
22. Vaz C, Ahmad H, Sharma P, et al. Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics. 2010;11(1):288.
23. Martí E, Pantano L, Bañez-Coronel M, et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010; 38(20):7219-7235.
24. Fernandez-Valverde SL, Taft RJ, Mattick JS. Dynamic isomiR regulation in Drosophila development. RNA. 2010;16(10):1881-1888.
25. Bortoluzzi S, Biasiolo M, Bisognin A. MicroRNA-offset RNAs (moRNAs): by-product spectators or functional players? Trends Mol Med. 2011;17(9): 473-474.
26. Shi W, Hendrix D, Levine M, Haley B. A distinct class of small RNAs arises from pre-miRNA-proximal regions in a simple chordate. Nat Struct Mol Biol. 2009;16(2):183-189.
27. Langenberger D, Bermudez-Santana C, Hertel J, Hoffmann S, Khaitovich P, Stadler PF. Evidence for human microRNA-offset RNAs in small RNA sequencing data. Bioinformatics. 2009;25(18): 2298-2301.
28. Taft RJ, Simons C, Nahkuri S, et al. Nuclearlocalized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat Struct Mol Biol. 2010;17(8):1030-1034.
29. Meiri E, Levy A, Benjamin H, et al. Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res. 2010;38(18):6234-6246.
30. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics. 2009;25(15):1991-1993.
31. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008;68(20):8191-8194.
32. Guo L, Liang T, Lu Z. A comprehensive study of multiple mapping and feature selection for correction strategy in the analysis of small RNAs from SOLiD sequencing. Biosystems. 2011;104(2):87-93.
33. Berezikov E, Robine N, Samsonova A, et al. Deep annotation of Drosophila melanogaster microRNAs yields insights into their processing, modification, and emergence. Genome Res. 2011;21(2):203-215.
34. Umbach JL, Strelow LI, Wong SW, Cullen BR. Analysis of rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected rhesus macaques. Virology. 2010;405(2):592-599.
35. Tuck AC, Tollervey D. RNA in pieces. Trends Genet. 2011;27(10):422-432.